You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Secondary Progress Multiple Sclerosis

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Individuals With Multiple Sclerosis, With Ataxia Symptoms, No Secondary Disease Affecting Balance Trial in Elazig (Kinesiotape)

Recruiting
  • Individuals With Multiple Sclerosis
  • +2 more
  • Kinesiotape
  • Elazığ, Turkey
  • +1 more
Apr 17, 2022

Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • +2 more
  • Ixazomib (NINLARO®) capsules / Matching placebo capsules
  • London, Greater London, United Kingdom
    Royal London Hospital, Barts Health NHS Foundation Trust
Feb 17, 2022

Measuring Active Microglia in Progressive Multiple Sclerosis

Completed
  • Secondary Progressive Multiple Sclerosis
  • [C11]PK-1195 PET scan
  • New York, New York
    Weill Cornell Medical College
Jan 14, 2022

Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic

Recruiting
  • Multiple Sclerosis, Primary Progressive
  • Multiple Sclerosis, Secondary Progressive
  • Magnetic Resonance Imaging
  • +3 more
  • Marseille, France
  • +1 more
Jan 14, 2022

Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Caen (Cognitive rehabilitation,

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Secondary Progressive Multiple Sclerosis
  • Cognitive rehabilitation
  • Standard Psychological care
  • Caen, Calvados, France
    University Hospital of Caen
Mar 8, 2022

Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

Active, not recruiting
  • Secondary Progressive Multiple Sclerosis
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Mar 29, 2022

Multiple Sclerosis Trial in France (DMT withdrawal, DMT continuation)

Recruiting
  • Multiple Sclerosis
  • DMT withdrawal
  • DMT continuation
  • Angers, France
  • +22 more
Mar 25, 2022

MS-ResearchBiomarkerS

Recruiting
  • Multiple Sclerosis
  • +10 more
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jan 26, 2022

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University School of Medicine
    Dec 30, 2021

    Imaging Interplay Between Axonal Damage and Repair in Multiple

    Recruiting
    • Multiple Sclerosis (MS)
    • +3 more
    • MRI
    • +2 more
    • Basel, Switzerland
      University Hospital Basel, Department of Neurology
    Dec 15, 2021

    Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Glostrup, Copenhagen, Denmark
    • +11 more
    May 3, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

    Active, not recruiting
    • Primary Progressive Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
    • ATA188
    • Placebo
    • La Jolla, California
    • +33 more
    Jul 21, 2022

    Secondary Progressive Multiple Sclerosis (SPMS) Trial in United Kingdom (Simvastatin, Placebo)

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis (SPMS)
    • Belfast, United Kingdom
    • +23 more
    Jul 4, 2022

    Multiple Sclerosis Trial in Latham (Cladribine Tablets)

    Recruiting
    • Multiple Sclerosis
    • Cladribine Tablets
    • Latham, New York
      Multiple Sclerosis Center of Northeastern New York, P.C.
    Jan 12, 2022

    Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy

    Recruiting
    • Active Secondary Progressive Multiple Sclerosis
    • siponimod
    • Ancona, AN, Italy
    • +19 more
    Dec 27, 2022

    Mayzent on SPMS Patients in a Long-term Non-interventional Study

    Recruiting
    • Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity
    • Siponimod
    • Baden, Aargau, Switzerland
    • +8 more
    May 16, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2021

    Secondary-progressive Multiple Sclerosis Trial in San Giovanni Rotondo, Terni, Lugano (Human Neural Stem Cells)

    Completed
    • Secondary-progressive Multiple Sclerosis
    • Human Neural Stem Cells
    • San Giovanni Rotondo, Foggia, Italy
    • +2 more
    Jul 9, 2021

    Progressive Multiple Sclerosis Trial in Thessaloniki (Early Harvest Extra Virgin Olive Oil)

    Completed
    • Progressive Multiple Sclerosis
    • Early Harvest Extra Virgin Olive Oil
    • Thessaloniki, Macedonia, Greece
      A' Department of Neurology,Aristotle University of Thessaloniki
    Jul 4, 2021

    Multiple Sclerosis Trial in Berlin (Sunphenon EGCG, Placebo)

    Completed
    • Multiple Sclerosis
    • Sunphenon EGCG
    • Placebo
    • Berlin, Germany
      Charité Universitätsmedizin Berlin (NeuroCure Clinical Research
    Jul 28, 2021

    MS - a Prospective Cohort Study

    Active, not recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • PASS-MS
    • Berlin, Germany
      Experimental and Clinical Research Center, Studienambulanz Neuro
    Aug 9, 2021

    Cortical Lesions in Patients With Multiple Sclerosis

    Completed
    • Multiple Sclerosis
    • +2 more
      • Hvidovre, Denmark
        Danish Research Centre for Magnetic Resonance
      Apr 6, 2021

      Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

      Completed
      Has Results
      • Relapsing-remitting Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
        • London, United Kingdom
          Imperial College NHS Trust
        Feb 11, 2021

        Relapsing Remitting Multiple Sclerosis, Secondary-progressive Multiple Sclerosis, Cognitive Deficits Trial in Yvoir (tDCS)

        Suspended
        • Relapsing Remitting Multiple Sclerosis
        • +3 more
        • tDCS
        • Yvoir, Namur, Belgium
          Department of Neurology, CHU Dinant Godinne UcL Namur
        Apr 28, 2021

        Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)

        Completed
        Has Results
        • Secondary Progressive Multiple Sclerosis
        • Primary Progressive Multiple Sclerosis
        • Dublin, Dublin 4, Ireland
        • +1 more
        Jul 8, 2021